N4 Pharma Plc (LON:N4P – Get Free Report)’s share price was down 1.3% on Tuesday . The company traded as low as GBX 0.75 ($0.01) and last traded at GBX 0.79 ($0.01). Approximately 277,177 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 1,085,318 shares. The stock had previously closed at GBX 0.80 ($0.01).
N4 Pharma Price Performance
The company has a current ratio of 14.86, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The company has a market capitalization of £1.73 million, a PE ratio of -64.50 and a beta of -0.07. The stock’s 50-day moving average is GBX 0.75 and its two-hundred day moving average is GBX 0.81.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Featured Articles
- Five stocks we like better than N4 Pharma
- What Makes a Stock a Good Dividend Stock?
- What is a Short Call Butterfly Spread? Explanation with Examples
- Stock Average Calculator
- First Quarter Wrap-Up Reveals Retail’s Shifting Sands
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Williams-Sonoma Stock Forecast to Hit $500? Here’s How
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
